CRISPR Cures for Cancer
Join the second annual CRISPR Cures for Cancer Symposium, a one-day event bringing together investigators from the CRISPR Cures for Cancer network. This tri-institutional initiative is dedicated to accelerating the design and development of novel cell therapies for cancer using cutting-edge genomic technologies.
Throughout the symposium, researchers will present their most recent findings, showcasing innovative applications of CRISPR and other genomic tools in the fight against cancer.
This year will also feature Nobel laureate Jennifer Doudna as a keynote speaker. Doudna, a pioneer in CRISPR technology, will share her insights on how genome editing will transform healthcare.
In addition to learning about the latest advancements, this symposium offers the space to foster collaborations and build connections with fellow scientists across institutions. Whether you’re an investigator, lab member, or collaborator, you’ll have the opportunity to share knowledge, spark new ideas, and drive future innovation in cancer research.
This event is open to researchers within the CRISPR Cures for Cancer initiative, their lab members, and members of Gladstone Institutes, UC San Francisco, and the Innovative Genomics Institute.
Program
9:00am | Welcome and Introduction Alex Marson, MD, PhD | Gladstone Institutes, UC San Francisco |
KEYNOTE ADDRESS | |
9:15am | CRISPR Biology and Biotechnology: How Genome Editing Will Transform Healthcare Jennifer Doudna, PhD | Gladstone Institutes, UC Berkeley |
10:15am | Break |
SESSION 1: FUNCTIONAL GENOMIC & PLATFORM DISCOVERY | |
10:30am | High-Content Medium-Throughput Screening of Organoid Co-Cultures to Identify Novel Therapeutic Strategies for Colon Cancer Jonathan Braverman, PhD | UC Berkeley |
10:50am | Dissecting Immune Hubs in Colon Cancer Using Spatial Profiling and Organoid-Based Models Karin Pelka, PhD | Gladstone Institutes, UC San Francisco |
11:10am | In Vitro Cancer Models with Genome-Engineered Human Stem Cells at Scale Hanqin Li, PhD | UC Berkeley |
11:30am | High-Throughput Genomics in Cancer Immunotherapy Ansu Satpathy, MD, PhD | Gladstone Institutes, Stanford University |
12:00pm | Break |
SESSION 2: PROJECT LIGHTNING TALKS | |
1:00pm | EvolvR-Mediated Diversification of Targeted Genomic Loci in Primary T Cells John Dueber, PhD | UC Berkeley |
1:10pm | Enhancing the Therapeutic Potential of Gene Edited Dendritic Cells and T Cells Through Functional Multiplexed Single Cell Analysis Matthew Spitzer, PhD | Gladstone Institutes, UC San Francisco |
1:20pm | Targeting KRas G12C Mutant Cancers Using Inhibitor-Specific CAR T-Cells Charles Craik, PhD | UC San Francisco |
1:30pm | Defining the Determinants of Response to Anti-BCMA CAR T Therapy in Multiple Myeloma Kai Wu, PhD | UC San Francisco |
1:40pm | Systematic Design and Development of Engineered Macrophages with Enhanced Anti-Tumor Functions Roarke Kamber, PhD | UC San Francisco |
1:50pm | In Vitro and In Silico Variant Functionalization Jimmie Ye, PhD | Gladstone Institutes, UC San Francisco |
SESSION 3: CELL THERAPY DEVELOPMENTS | |
2:00pm | Home Grown Cell Therapies for Pancreatic Cancer Greg Allen, MD, PhD | UC San Francisco |
2:20pm | Developing Cures for Cancer Brian Shy, MD, PhD | Gladstone Institutes, UC San Francisco |
2:40pm | Break |
SESSION 4: ENGINEERING CELL THERAPIES | |
3:20pm | Gene Editing with Lipid Nanoparticle/mRNA Complexes Niren Murthy, PhD | UC Berkeley |
3:40pm | Synthetic Receptors to Expand the Disease Sensing Ability of Engineered T Cells Kole Roybal, PhD | Gladstone Institutes, UC San Francisco |
4:00pm | Leveraging Diverse Functional Screens in Human T Cells to Guide T Cell Therapy Engineering Julia Carnevale, MD | Gladstone Institutes, UC San Francisco |
4:20pm | Improving T Cell Manufacturing via Enzyme Engineering and Streamlined Delivery Ross Wilson, PhD | UC Berkeley |
4:40pm | In Vivo CRISPR Editing to Reprogram T Cell Function Justin Eyquem, PhD | Gladstone Institutes, UC San Francisco |
5:00pm | Closing Alan Ashworth, PhD, FRS | UC San Francisco |
5:05pm | Reception |
CRISPR Cures for Cancer is a tri-institutional initiative to accelerate cell therapy design and development using genomic technologies. CRISPR Cures for Cancer unites researchers at UC San Francisco, Gladstone Institutes, and the Innovative Genomics Institute at UC Berkeley to accelerate the development of novel therapies for a wide variety of cancers by combining genetic discovery and design with innovations in CRISPR technology.
Details
Dates
November 21, 2024Time
9:00am-5:00pm PSTLocation
Mahley AuditoriumContact(s)
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.